600807 Jinan High-tech Development
- 3.01
- 0.000.00%
Jinan High-tech Development News
Declining Stock and Solid Fundamentals: Is The Market Wrong About Jinan High-tech Development Co., Ltd. (SHSE:600807)?
With its stock down 17% over the past week, it is easy to disregard Jinan High-tech Development (SHSE:600807). But if you pay close attention, you might gather that its strong financials could mean
Revenues Not Telling The Story For Jinan High-tech Development Co., Ltd. (SHSE:600807) After Shares Rise 31%
Jinan High-tech Development Co., Ltd. (SHSE:600807) shareholders are no doubt pleased to see that the share price has bounced 31% in the last month, although it is still struggling to make up recently
Jinan High-tech Development (SHSE:600807) Adds CN¥363m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 44%
Jinan High-tech Development Co., Ltd. (SHSE:600807) shareholders will doubtless be very grateful to see the share price up 32% in the last month. But if you look at the last five years the returns
Jinan Hi-Tech (600807.SH): The original overseas business has been divested
Gelonghui, Feb. 8: Jinan Hi-Tech (600807.SH) said on an interactive platform that the company's original overseas business has been divested.
Jinan Hi-Tech (600807.SH) plans to acquire bonds related to Yongan Real Estate with a purchase price of 455.6928 million yuan
Jinan Gaoxin (600807.SH) issued an announcement. The company and its wholly-owned subsidiary Jinan Gaoxin Biotechnology Co., Ltd. (...
Jinan Hi-Tech (600807.SH): Signed “Debt Transfer Contract” and other agreements
Gelonghui, Feb. 2: Jinan Hi-Tech (600807.SH) announced that the company and its wholly-owned subsidiary Jinan Hi-Tech Biotechnology Co., Ltd. signed a “Debt Transfer Contract” and “Guarantee Contract” with Shandong Financial Asset Management Co., Ltd., to acquire the claims of Shandong Financial Assets against the wholly-owned subsidiary Shandong Yongan Real Estate Development Co., Ltd. The purchase price was 4556.928 million yuan. The company paid the above amounts and corresponding capital occupancy fees in installments. Jigao Biotech provided joint and several liability guarantees for the above matters.
Jinan High-tech Development Co., Ltd.'s (SHSE:600807) Price Is Out Of Tune With Revenues
Jinan High-tech Development Co., Ltd.'s (SHSE:600807) price-to-sales (or "P/S") ratio of 2.4x may not look like an appealing investment opportunity when you consider close to half the companies in the
Jinan Hi-Tech (600807.SH): The holding subsidiary passed the high-tech enterprise certification
Gelonghui, January 2, Jinan Hi-Tech (600807.SH) announced that according to the “Notice on Filing the Second Batch of High-tech Enterprises for the 2023 Certification Report” issued by the National High-tech Enterprise Certification and Management Leading Group Office, the holding subsidiaries of the company, Shandong Ikwell Biotechnology Co., Ltd., and Shandong Ikwell Medical Laboratory Co., Ltd. have passed the high-tech enterprise certification. The certificate numbers are: GR202337006433 and GR202337007058, which are valid for three years. The certification of a high-tech enterprise this time is the original proof of Ikwell Biotech
Jinan Hi-Tech (600807.SH): The company's fundamentals have not changed
Gelonghui (600807.SH) announced on December 14|Jinan Hi-Tech () announced that on December 11, December 12, and December 13, 2023, the company's stock closed for three consecutive trading days with a cumulative price increase of more than 20%, which is an abnormal fluctuation in stock trading. On December 14, 2023, the company's stock rose and stopped again. It has been rising and stopped for three consecutive trading days, with a cumulative increase of large cumulative gains. In view of the recent large fluctuations in the company's stock price, the company's fundamentals have not changed. According to the rolling price-earnings ratio and net market ratio (SEC industry classification) published by China Securities Index Co., Ltd., the latest rolling of the company's industry
Are Strong Financial Prospects The Force That Is Driving The Momentum In Jinan High-tech Development Co., Ltd.'s SHSE:600807) Stock?
Jinan High-tech Development's (SHSE:600807) stock is up by a considerable 26% over the past three months. Given the company's impressive performance, we decided to study its financial indicators mor
Jinan Hi-Tech (600807.SH) subsidiary plans to transfer 100% of Jigao Ecology's shares to speed up divestment and monetization of non-main business assets
Jinan Hi-Tech (600807.SH) issued an announcement to focus on the development of the core business of life and health and accelerate non-main business assets...
Jinan Hi-Tech (600807.SH) and related responsible personnel received a warning letter from the Shandong Regulatory Bureau due to inaccurate credit disclosure
Jinan Hi-Tech (600807.SH) issued an announcement. The company recently received supervision from Shandong by the China Securities Regulatory Commission...
[BT Financial Report Instantaneous Analysis] Jinan Hi-Tech 2023 Quarterly Report: Mining business affects performance, and the landscaping and in vitro diagnostics industry has broad prospects
This financial report was announced on 2023-10-27 18:13:23 Jinan Gaoxin (stock code: 600807) is an enterprise with broad market prospects in the in vitro diagnosis industry and landscaping industry in China. Despite weak global economic growth in the first half of 2023 and the complex domestic macro environment, the central government adheres to the general tone of steady progress and continues to support the steady and healthy development of the real estate market, providing a favorable development environment for real estate companies. In terms of assets and liabilities, total assets at the end of the reporting period were $3.398 billion, down from $4 billion at the end of the previous year.
Bailian Co., Ltd. (600827.SH): Plans to upgrade the first phase and develop the second phase of the Jinan High-tech Bailian Outlet Plaza project
On August 14, GLONGHUI | Bailian Co., Ltd. (600827.SH) announced that the company plans to upgrade the first phase of the Jinan High-tech Bailian Outlet Plaza project and develop the second phase. Through environmental and scenario transformation and upgrading, the overall range of operations will be expanded to create an urban resort space. In order to facilitate the construction of the Jinan Gaoxin Bailian Outlet Plaza project, the company plans to acquire 10% of the shares of Jinan Bailian Commercial Management Co., Ltd. held by Jinan Huayu Real Estate Co., Ltd. After the above equity acquisition is completed, the company plans to increase the capital of Jinan Bailian Commercial Management Co., Ltd. to achieve further stable operation, expansion of business format, and complementary linkage to satisfy
Jinan High-tech Development to Set Up New Unit For Global Expansion
Jinan High-tech Development (SHA:600807) plans to establish a new subsidiary called Jinan BioTech (Shandong) to facilitate its global health business expansion. The Chinese department store operator w
Jinan Hi-Tech (600807.SH): Proposed capital reduction for industrial investment partnerships
On August 7, GLONGHUI | Jinan Hi-Tech (600807.SH) announced that the wholly-owned subsidiary Jinan Hi-Tech Biotechnology Co., Ltd. plans to reduce its pledge investment amount by 29.5 million yuan to the Jinan Jigao Health Industry Investment Partnership Co., Ltd., which is co-invested by affiliated parties Shandong Shunying Equity Investment Fund Management Co., Ltd. and Jinan High-tech Treasury Investment Co., Ltd. The investment amount involved in this capital cut has not yet been actually paid.
Jinan Hi-Tech (600807.SH): Establishing a subsidiary, Ji'an Biotech to promote the internationalization of the main life and health industry
According to the Zhitong Finance App, Jinan Hi-Tech (600807.SH) announced that Jigao Biotech, a wholly-owned subsidiary of the company, and Minggar Company, a wholly-owned overseas subsidiary, jointly invested 18 million US dollars to establish Ji'an Biotech. Of these, Jigao Biotech invested 900,000 US dollars in equivalent foreign currency, accounting for 5%, and Mingal invested 17.1 million US dollars in equivalent foreign currency, accounting for 95%. The establishment of a subsidiary this time is conducive to promoting the international expansion of the company's main life and health business, and is in line with the company's development strategy.
Jinan Hi-Tech (600807.SH): The subsidiary was identified as a Gazelle enterprise in Shandong Province
Glonway July 26丨Jinan Hi-Tech (600807.SH) announced that recently, according to the “Notice Concerning the Announcement of Gazelle and Unicorn Enterprises in Shandong Province in 2023” (Lu Gong Xinchuang (2023) No. 138) issued by the Shandong Provincial Department of Industry and Information Technology (Lu Gong Xinchuang (2023) No. 138), after review, the company's subsidiary Shandong Ekway Biotechnology Co., Ltd. (“Ekway Biology” for short) was recognized as the 2023 Shandong Gazelle Enterprise, which is valid until December 31, 2026.
Jinan High-tech Development's (SHSE:600807) Solid Profits Have Weak Fundamentals
Jinan High-tech Development Co., Ltd.'s (SHSE:600807) stock was strong after they recently reported robust earnings. However, we think that shareholders may be missing some concerning details in the
Express News | Jinan High-tech Development Chairman Resigns
Analysis
Price Target
No Data
